Ifp Advisors, Inc Summit Therapeutics Inc. Transaction History
Ifp Advisors, Inc
- $2.91 Billion
- Q4 2024
A detailed history of Ifp Advisors, Inc transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 504 shares of SMMT stock, worth $10,332. This represents 0.0% of its overall portfolio holdings.
Number of Shares
504
Previous 500
0.8%
Holding current value
$10,332
Previous $10,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SMMT
# of Institutions
202Shares Held
76.3MCall Options Held
2.01MPut Options Held
2.83M-
Baker Bros. Advisors LP New York, NY24.4MShares$501 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$224 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$162 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$112 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$71.1 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.12B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...